Clinical Trials Browser

Phase NA × Hearing Loss × 30 days × Clear all

NCT07622407 2026-06-03

TIMELY REHAB

Ototoxicity, Deglutition Disorders, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Tinnitus, Hearing Loss, Drug-Related Side Effects and Adverse Reactions